ConductScience.org, home

Paper39190889

Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease.

Distenhreft JIQ and 6 others. J Bras Nefrol, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease. Papers, record 39190889. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39190889

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease.
PubMed
Journal
J Bras Nefrol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Multicenter Study
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
1.17, provisional
iCite
Revised in PubMed
2024-09-18
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Distenhreft JIQJesiree Iglésias Quadroshttps://orcid.org/0000-0002-9313-1899
2Couto-Lima DDinairhttps://orcid.org/0000-0003-2043-6306
3Andreazzi CSCecilia Siliansky dehttps://orcid.org/0000-0002-9817-0635
4Thomazini JFRCJuliana Feu Rosa Carrerahttps://orcid.org/0009-0001-3976-4425
5Vasconcellos Filho LMLauro Monteirohttps://orcid.org/0000-0002-7437-4748
6Falqueto AAloísiohttps://orcid.org/0009-0009-8044-5504
7Luchi WMWeverton Machadohttps://orcid.org/0000-0001-5762-8921

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Yellow Fever VaccineMajor topic
Kidney Failure, ChronicMajor topic
Yellow FeverMajor topic
Humans
Retrospective Studies
Male
Female
Middle Aged
Aged
Adult
Immunogenicity, Vaccine
Renal Dialysis
Young Adult
Aged, 80 and over
Brazil

Source PubMed

Download CSV of topics

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122093046Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study.Transpl Infect Dis2012https://conductscience.org/library/papers/22093046PubMed
210971154Adequate seroresponse to influenza vaccination in dialysis patients.Nephron2000https://conductscience.org/library/papers/10971154PubMed
323834702Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation.Am J Transplant2013https://conductscience.org/library/papers/23834702PubMed
427208638Yellow fever vaccination status and safety in hemodialysis patients.Int J Infect Dis2016https://conductscience.org/library/papers/27208638PubMed
516055233Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004.Vaccine2005https://conductscience.org/library/papers/16055233PubMed
619287931[Vaccination against yellow fever among patients on immunosuppressors with diagnoses of rheumatic diseases].Rev Soc Bras Med Trop2009https://conductscience.org/library/papers/19287931PubMed
722627101Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in Mali.Trans R Soc Trop Med Hyg2012https://conductscience.org/library/papers/22627101PubMed
828591405Genome analysis of yellow fever virus of the ongoing outbreak in Brazil reveals polymorphisms.Mem Inst Oswaldo Cruz2017https://conductscience.org/library/papers/28591405PubMed
912806465[Yellow Fever].Rev Soc Bras Med Trop2003https://conductscience.org/library/papers/12806465PubMed
1031585683Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation.Am J Kidney Dis2020https://conductscience.org/library/papers/31585683PubMed
1121718741Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model.Vaccine2011https://conductscience.org/library/papers/21718741PubMed
1219191654Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients.Clin Infect Dis2009https://conductscience.org/library/papers/19191654PubMed
1324006295Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.Am J Trop Med Hyg2013https://conductscience.org/library/papers/24006295PubMed
1433423842Hepatitis B virus vaccine and chronic kidney disease. The advances.Nefrologia (Engl Ed)2021https://conductscience.org/library/papers/33423842PubMed
1522267015Plasma HIV-RNA is the key determinant of long-term antibody persistence after Yellow fever immunization in a cohort of 364 HIV-infected patients.J Acquir Immune Defic Syndr2012https://conductscience.org/library/papers/22267015PubMed
1633656136Adverse events following yellow fever vaccination in immunocompromised persons.Rev Inst Med Trop Sao Paulo2021https://conductscience.org/library/papers/33656136PubMed
1732765496Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study.Front Immunol2020https://conductscience.org/library/papers/32765496PubMed
1828687779Potential risk of re-emergence of urban transmission of Yellow Fever virus in Brazil facilitated by competent Aedes populations.Sci Rep2017https://conductscience.org/library/papers/28687779PubMed
1925418753Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever.Arthritis Rheumatol2015https://conductscience.org/library/papers/25418753PubMed
2018701615Aspects of immune dysfunction in end-stage renal disease.Clin J Am Soc Nephrol2008https://conductscience.org/library/papers/18701615PubMed

See all 23 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42411915A Systematic Review on Yellow Fever Vaccine and Adverse Events.Glob Health Epidemiol Genom2026https://conductscience.org/library/papers/42411915PubMed
42079457Vaccine efficacy in CKD patients not on dialysis: a systematic review and meta-analysis.Clin Kidney J2026https://conductscience.org/library/papers/42079457PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39190889

GET https://conductscience.org/api/papers/v1/39190889/references?page=2